# Yong Li

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yong-li/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,341 |
| Field | Military Technology and Strategies |
| h-index | 83 |
| i10-index | 509 |
| Last Known Institution | Hengshui University |
| OpenAlex ID | https://openalex.org/A5029768249 |
| ORCID iD | 0000-0002-8910-9787 |
| Works | 3,300 |

## Researcher papers

Showing 12 of 13.

- [Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression](https://scholariq.org/papers/metabolomic-profiles-delineate-potential-role-for-sarcosine-in-prostate-cancer/)
- [An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression](https://scholariq.org/papers/an-integrated-network-of-androgen-receptor-polycomb-and-tmprss2-erg-gene-fusions/)
- [Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1](https://scholariq.org/papers/exosomal-transfer-of-stroma-derived-mir21-confers-paclitaxel-resistance-in/)
- [MicroRNA-155 Functions as an OncomiR in Breast Cancer by Targeting the <i>Suppressor of Cytokine Signaling 1</i> Gene](https://scholariq.org/papers/microrna-155-functions-as-an-oncomir-in-breast-cancer-by-targeting-the-i/)
- [Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial](https://scholariq.org/papers/niraparib-monotherapy-for-late-line-treatment-of-ovarian-cancer-quadra-a/)
- [Nucleic acid aptamers and enzymes as sensors](https://scholariq.org/papers/nucleic-acid-aptamers-and-enzymes-as-sensors/)
- [Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells](https://scholariq.org/papers/estradiol-downregulates-mir-21-expression-and-increases-mir-21-target-gene/)
- [Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance](https://scholariq.org/papers/acquisition-of-epithelial-mesenchymal-transition-and-cancer-stem-cell-phenotypes/)
- [A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells](https://scholariq.org/papers/a-novel-mir-155-mir-143-cascade-controls-glycolysis-by-regulating-hexokinase-2/)
- [A Keystone Transform Without Interpolation for SAR Ground Moving-Target Imaging](https://scholariq.org/papers/a-keystone-transform-without-interpolation-for-sar-ground-moving-target-imaging/)
- [Cancer stem cells: A contentious hypothesis now moving forward](https://scholariq.org/papers/cancer-stem-cells-a-contentious-hypothesis-now-moving-forward/)
- [miR‐301a as an NF‐κB activator in pancreatic cancer cells](https://scholariq.org/papers/mir-301a-as-an-nf-b-activator-in-pancreatic-cancer-cells/)

## Researcher topics

- [Military Technology and Strategies](https://scholariq.org/topics/military-technology-and-strategies/)
- [Legal and Regulatory Analysis](https://scholariq.org/topics/legal-and-regulatory-analysis/)
- [Linguistic, Cultural, and Literary Studies](https://scholariq.org/topics/linguistic-cultural-and-literary-studies/)
- [Medical Research and Treatments](https://scholariq.org/topics/medical-research-and-treatments/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

## Researcher university

- [Hengshui University](https://scholariq.org/institutions/hengshui-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.